As of 31 Dec 2025, 1 institutional investors reported holding 1 shares of ABIOMED INC - COMMON STOCK (ABMD).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 1 | $381 | $381.00 | 1 | |
| 2025 Q3 | 1 | $381 | $381.00 | 1 | |
| 2025 Q2 | 1 | $381 | $381.00 | 1 | |
| 2025 Q1 | 1 | $381 | $381.00 | 1 | |
| 2024 Q4 | 1 | $381 | $381.00 | 1 | |
| 2024 Q3 | 1 | $381 | $381.00 | 1 | |
| 2024 Q2 | 1 | $381 | $381.00 | 1 | |
| 2024 Q1 | 1 | $381 | $381.00 | 1 | |
| 2023 Q4 | 1 | $381 | $381.00 | 1 | |
| 2023 Q3 | 1 | $381 | $381.00 | 1 | |
| 2023 Q2 | 1 | $381 | -$1,501,000 | $381.00 | 1 |
| 2023 Q1 | 3,940 | $1,501,381 | -$1,939,000 | $381.03 | 2 |
| 2022 Q4 | 6,093 | $1,622,381 | -$9,660,773,699 | $245.77 | 5 |
| 2022 Q3 | 43,045,451 | $10,580,189,287 | +$95,192,070 | $245.66 | 501 |
| 2022 Q2 | 42,578,545 | $10,541,053,121 | +$88,697,885 | $247.51 | 480 |
| 2022 Q1 | 42,305,413 | $14,003,877,662 | +$110,794,797 | $331.24 | 480 |
| 2021 Q4 | 41,983,050 | $15,070,561,721 | +$149,940,642 | $359.17 | 479 |
| 2021 Q3 | 41,252,237 | $13,425,862,553 | -$108,231,901 | $325.52 | 488 |
| 2021 Q2 | 41,553,043 | $12,963,955,236 | +$251,293,533 | $312.11 | 468 |
| 2021 Q1 | 41,370,032 | $13,181,528,915 | -$445,182,680 | $318.73 | 477 |
| 2020 Q4 | 42,734,450 | $13,848,885,903 | -$4,981,296 | $324.20 | 486 |
| 2020 Q3 | 42,791,316 | $11,846,117,605 | -$143,939,284 | $277.06 | 488 |
| 2020 Q2 | 43,313,530 | $10,461,088,474 | +$169,851,857 | $241.56 | 442 |
| 2020 Q1 | 42,991,095 | $6,241,249,550 | -$230,659,537 | $145.16 | 396 |
| 2019 Q4 | 44,227,938 | $7,543,605,745 | +$435,547,600 | $170.59 | 454 |
| 2019 Q3 | 41,422,068 | $7,367,508,771 | -$116,440,964 | $177.89 | 425 |
| 2019 Q2 | 41,833,685 | $10,895,359,280 | +$619,287,692 | $260.49 | 474 |
| 2019 Q1 | 39,801,136 | $11,365,695,137 | +$9,456,198 | $285.59 | 552 |
| 2018 Q4 | 39,571,131 | $12,855,968,811 | -$144,031,625 | $325.04 | 519 |
| 2018 Q3 | 39,791,657 | $17,882,191,790 | +$419,688,787 | $449.75 | 517 |
| 2018 Q2 | 38,968,676 | $15,936,433,485 | -$65,003,458 | $409.05 | 517 |
| 2018 Q1 | 38,929,456 | $11,325,506,269 | +$28,066,563 | $290.99 | 397 |
| 2017 Q4 | 39,090,647 | $7,324,600,980 | -$291,121,423 | $187.41 | 354 |
| 2017 Q3 | 40,568,304 | $6,837,026,350 | +$110,025,270 | $168.60 | 316 |
| 2017 Q2 | 40,007,980 | $5,732,113,437 | -$45,630,671 | $143.30 | 302 |
| 2017 Q1 | 40,508,012 | $5,069,303,978 | +$424,292,855 | $125.20 | 287 |
| 2016 Q4 | 40,198,324 | $4,529,145,070 | +$67,746,251 | $112.68 | 294 |
| 2016 Q3 | 39,544,189 | $5,079,165,603 | -$111,515,239 | $128.58 | 302 |
| 2016 Q2 | 40,504,087 | $4,426,318,221 | -$115,837,262 | $109.29 | 292 |
| 2016 Q1 | 40,507,103 | $3,840,171,127 | +$73,358,560 | $94.81 | 265 |
| 2015 Q4 | 39,914,795 | $3,603,757,954 | +$9,177,983 | $90.28 | 245 |
| 2015 Q3 | 39,758,239 | $3,686,723,440 | -$92,924,795 | $92.76 | 238 |
| 2015 Q2 | 40,389,638 | $2,653,324,243 | +$31,010,741 | $65.73 | 227 |
| 2015 Q1 | 39,437,764 | $2,822,892,992 | -$155,092,863 | $71.58 | 207 |
| 2014 Q4 | 42,401,511 | $1,613,970,692 | -$146,223,135 | $38.06 | 156 |
| 2014 Q3 | 47,786,216 | $1,186,411,346 | +$6,136,699 | $24.83 | 137 |
| 2014 Q2 | 47,364,312 | $1,190,826,988 | -$15,084,270 | $25.14 | 138 |
| 2014 Q1 | 43,104,796 | $1,121,552,219 | +$101,281,963 | $26.04 | 136 |